Irritable Bowel Syndrome (IBS) Market Report

Global and Europe Irritable Bowel Syndrome (IBS) Market Professional Survey Report 2019

  • POSTDATE：Jun 20, 2020
  • PAGES：196
  • REPORT CODE：GMM564638
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Global Irritable Bowel Syndrome (IBS) market was valued at XX.0 million US$ in 2018, with the CAGR of 3.7%, this market is estimated to reach USD XX.0 million US$ in 2026.

    This report mainly elaborates on the segmentation, end-user, size, share, trend, future demand and leading players with respect to the Global and Europe Irritable Bowel Syndrome (IBS) market. Describe product range of Irritable Bowel Syndrome (IBS), market overview, market opportunities, market drivers, limitations, PEST and SWOT analysis. Introducing market share, production, consumption, revenue, and growth of Global major regions from 2014-2019 and forecast to 2026.

    The report also provides a detailed analysis of the Europe Irritable Bowel Syndrome (IBS) market from 2014 to 2026 based on the product type and end-user. It provides a detailed overview of the market of the top 16 countries of Europe along with top companies' data analysis and product introductions of Europe Irritable Bowel Syndrome (IBS) market.

     

    By Player

    • McNeil Consumer Healthcare

    • Sucampo Pharmaceuticals

    • Sebela Pharmaceuticals

    • IM HealthScience

    • Astellas Pharmaceuticals

    • Allergan

    • Valeant Pharmaceuticals

    • Takeda

    By Type

    • IBS-D Drug

    • IBS-C Drug

    • Others

    By End-User

    • Women

    • Men

    By Region

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Netherlands

    • Portugal

    • Denmark

    • Finland

    • Iceland

    • Norway

    • Sweden

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Irritable Bowel Syndrome (IBS) Market

    • 1.3 Market Segment by Type

      • 1.3.1 Global Irritable Bowel Syndrome (IBS) Market Size and Growth Rate of IBS-D Drug from 2014 to 2026

      • 1.3.2 Global Irritable Bowel Syndrome (IBS) Market Size and Growth Rate of IBS-C Drug from 2014 to 2026

      • 1.3.3 Global Irritable Bowel Syndrome (IBS) Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Global Irritable Bowel Syndrome (IBS) Market Size and Growth Rate of Women from 2014 to 2026

      • 1.4.2 Global Irritable Bowel Syndrome (IBS) Market Size and Growth Rate of Men from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 North America Irritable Bowel Syndrome (IBS) Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Irritable Bowel Syndrome (IBS) Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Irritable Bowel Syndrome (IBS) Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 LAMEA Irritable Bowel Syndrome (IBS) Consumption Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Irritable Bowel Syndrome (IBS) Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Irritable Bowel Syndrome (IBS) by Major Types

      • 3.4.1 Irritable Bowel Syndrome (IBS) Market Size and Growth Rate of IBS-D Drug

      • 3.4.2 Irritable Bowel Syndrome (IBS) Market Size and Growth Rate of IBS-C Drug

      • 3.4.3 Irritable Bowel Syndrome (IBS) Market Size and Growth Rate of Others

    4 Segmentation of Irritable Bowel Syndrome (IBS) Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Irritable Bowel Syndrome (IBS) by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Irritable Bowel Syndrome (IBS) for Women

      • 4.4.2 Market Size and Growth Rate of Irritable Bowel Syndrome (IBS) for Men

    5 Market Analysis by Major Regions

    • 5.1 Global Irritable Bowel Syndrome (IBS) Production Analysis by Top Regions

    • 5.2 Global Irritable Bowel Syndrome (IBS) Consumption Analysis by Top Regions

    • 5.3 Global Irritable Bowel Syndrome (IBS) Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Irritable Bowel Syndrome (IBS) Production, Import, Consumption and Export Analysis

      • 5.3.2 Europe Irritable Bowel Syndrome (IBS) Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Irritable Bowel Syndrome (IBS) Production, Import, Consumption and Export Analysis

      • 5.3.4 LAMEA Irritable Bowel Syndrome (IBS) Production, Import, Consumption and Export Analysis

    6 Product Circulation of Irritable Bowel Syndrome (IBS) Market among Top Countries

    • 6.1 Top 5 Export Countries in Irritable Bowel Syndrome (IBS) Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Irritable Bowel Syndrome (IBS) Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Irritable Bowel Syndrome (IBS) Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Irritable Bowel Syndrome (IBS) Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Irritable Bowel Syndrome (IBS) Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Irritable Bowel Syndrome (IBS) Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. North America Irritable Bowel Syndrome (IBS) Landscape Analysis

    • 7.1 North America Irritable Bowel Syndrome (IBS) Landscape Analysis by Top Countries

      • 7.1.1 United States Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate

      • 7.1.2 Canada Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate

      • 7.1.3 Mexico Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate

    8. Europe Irritable Bowel Syndrome (IBS) Landscape Analysis

    • 8.1 Europe Irritable Bowel Syndrome (IBS) Landscape Analysis by Major Types

    • 8.2 Europe Irritable Bowel Syndrome (IBS) Landscape Analysis by Major End-Users

    • 8.3 Europe Irritable Bowel Syndrome (IBS) Landscape Analysis by Top Countries

      • 8.3.1 Germany Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate

      • 8.3.2 UK Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate

      • 8.3.3 France Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate

      • 8.3.4 Italy Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate

      • 8.3.5 Spain Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate

      • 8.3.6 Belgium Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate

      • 8.3.7 Poland Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate

      • 8.3.8 Russia Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate

      • 8.3.9 Turkey Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate

      • 8.3.10 Netherlands Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate

      • 8.3.11 Portugal Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate

      • 8.3.12 Denmark Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate

      • 8.3.13 Finland Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate

      • 8.3.14 Iceland Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate

      • 8.3.15 Norway Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate

      • 8.3.16 Sweden Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate

    • 8.4 Top 3 Players Profiles in Europe

    9 Asia Pacific Irritable Bowel Syndrome (IBS) Landscape Analysis

    • 9.1 Asia Pacific Irritable Bowel Syndrome (IBS) Landscape Analysis by Top Countries

      • 9.1.1 China Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate

      • 9.1.2 Japan Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate

      • 9.1.3 Australia and New Zealand (ANZ) Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate

      • 9.1.4 India Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate

      • 9.1.5 ASEAN Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate

      • 9.1.6 South Korea Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate

    10 LAMEA Irritable Bowel Syndrome (IBS) Landscape Analysis

    • 10.1 LAMEA Irritable Bowel Syndrome (IBS) Landscape Analysis by Top Countries

      • 10.1.1 GCC Countries Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate

      • 10.1.2 Brazil Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate

      • 10.1.3 North Africa Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate

      • 10.1.4 South Africa Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate

      • 10.1.5 Argentina Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate

    11 Major Players Profiles

    • 11.1 McNeil Consumer Healthcare

      • 11.1.1 McNeil Consumer Healthcare Company Profile and Development Status

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Sucampo Pharmaceuticals

      • 11.2.1 Sucampo Pharmaceuticals Company Profile and Development Status

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Sebela Pharmaceuticals

      • 11.3.1 Sebela Pharmaceuticals Company Profile and Development Status

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 IM HealthScience

      • 11.4.1 IM HealthScience Company Profile and Development Status

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Astellas Pharmaceuticals

      • 11.5.1 Astellas Pharmaceuticals Company Profile and Development Status

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Allergan

      • 11.6.1 Allergan Company Profile and Development Status

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Valeant Pharmaceuticals

      • 11.7.1 Valeant Pharmaceuticals Company Profile and Development Status

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 Takeda

      • 11.8.1 Takeda Company Profile and Development Status

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 95 Figures and 144 Tables)

    • Figure Product Picture

    • Figure Irritable Bowel Syndrome (IBS) Market Size and Growth Rate of IBS-D Drug from 2014 to 2026

    • Figure Irritable Bowel Syndrome (IBS) Market Size and Growth Rate of IBS-C Drug from 2014 to 2026

    • Figure Irritable Bowel Syndrome (IBS) Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Global Irritable Bowel Syndrome (IBS) Market Size and Growth Rate of Women from 2014 to 2026

    • Figure Global Irritable Bowel Syndrome (IBS) Market Size and Growth Rate of Men from 2014 to 2026

    • Figure North America Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

    • Figure United States Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

    • Figure UK Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

    • Figure France Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

    • Figure China Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

    • Figure Australia Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

    • Figure India Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

    • Figure LAMEA Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

    • Figure North Africa Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Irritable Bowel Syndrome (IBS) Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Irritable Bowel Syndrome (IBS)

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Irritable Bowel Syndrome (IBS) by Different Types from 2014 to 2026

    • Table Consumption Share of Irritable Bowel Syndrome (IBS) by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of IBS-D Drug

    • Figure Market Size and Growth Rate of IBS-C Drug

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Irritable Bowel Syndrome (IBS) by Different End-Users from 2014 to 2026

    • Table Consumption Share of Irritable Bowel Syndrome (IBS) by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Women

    • Figure Market Size and Growth Rate of Men

    • Table Global Irritable Bowel Syndrome (IBS) Production by Major Regions

    • Table Global Irritable Bowel Syndrome (IBS) Production Share by Major Regions

    • Table Global Irritable Bowel Syndrome (IBS) Consumption by Major Regions

    • Table Global Irritable Bowel Syndrome (IBS) Consumption Share by Major Regions

    • Table North America Irritable Bowel Syndrome (IBS) Production, Import, Consumption and Export Analysis

    • Table Europe Irritable Bowel Syndrome (IBS) Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Irritable Bowel Syndrome (IBS) Production, Import, Consumption and Export Analysis

    • Table LAMEA Irritable Bowel Syndrome (IBS) Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Irritable Bowel Syndrome (IBS) Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Irritable Bowel Syndrome (IBS) Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Irritable Bowel Syndrome (IBS) Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Irritable Bowel Syndrome (IBS) Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Irritable Bowel Syndrome (IBS) Consumption by Major Countries from 2014 to 2026

    • Table North America Irritable Bowel Syndrome (IBS) Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Irritable Bowel Syndrome (IBS) Consumption Share by Major Countries in 2014

    • Figure North America Irritable Bowel Syndrome (IBS) Consumption Share by Major Countries in 2018

    • Figure North America Irritable Bowel Syndrome (IBS) Consumption Share by Major Countries in 2026

    • Figure United States Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Irritable Bowel Syndrome (IBS) Consumption by Types from 2014 to 2026

    • Table Europe Irritable Bowel Syndrome (IBS) Consumption Share by Types from 2014 to 2026

    • Table Europe Irritable Bowel Syndrome (IBS) Consumption by End-Users from 2014 to 2026

    • Table Europe Irritable Bowel Syndrome (IBS) Consumption Share by End-Users from 2014 to 2026

    • Table Europe Irritable Bowel Syndrome (IBS) Consumption by Major Countries from 2014 to 2026

    • Table Europe Irritable Bowel Syndrome (IBS) Consumption Share by Major Countries from 2014 to 2026

    • Figure Germany Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate from 2014 to 2026

    • Figure France Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate from 2014 to 2026

    • Figure Spain Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate from 2014 to 2026

    • Figure Portugal Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate from 2014 to 2026

    • Figure Denmark Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Irritable Bowel Syndrome (IBS) Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Irritable Bowel Syndrome (IBS) Consumption Share by Major Countries from 2014 to 2026

    • Figure China Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate from 2014 to 2026

    • Figure India Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption Share by Major Countries from 2014 to 2026

    • Figure GCC Countries Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Countries Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate from 2014 to 2026

    • Figure North Africa Countries Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Countries Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Countries Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of McNeil Consumer Healthcare

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of McNeil Consumer Healthcare

    • Figure Sales and Growth Rate Analysis of McNeil Consumer Healthcare

    • Figure Revenue and Market Share Analysis of McNeil Consumer Healthcare

    • Table Product and Service Introduction of McNeil Consumer Healthcare

    • Table Company Profile and Development Status of Sucampo Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sucampo Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Sucampo Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Sucampo Pharmaceuticals

    • Table Product and Service Introduction of Sucampo Pharmaceuticals

    • Table Company Profile and Development Status of Sebela Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sebela Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Sebela Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Sebela Pharmaceuticals

    • Table Product and Service Introduction of Sebela Pharmaceuticals

    • Table Company Profile and Development Status of IM HealthScience

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of IM HealthScience

    • Figure Sales and Growth Rate Analysis of IM HealthScience

    • Figure Revenue and Market Share Analysis of IM HealthScience

    • Table Product and Service Introduction of IM HealthScience

    • Table Company Profile and Development Status of Astellas Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Astellas Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Astellas Pharmaceuticals

    • Table Product and Service Introduction of Astellas Pharmaceuticals

    • Table Company Profile and Development Status of Allergan

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allergan

    • Figure Sales and Growth Rate Analysis of Allergan

    • Figure Revenue and Market Share Analysis of Allergan

    • Table Product and Service Introduction of Allergan

    • Table Company Profile and Development Status of Valeant Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Valeant Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Valeant Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Valeant Pharmaceuticals

    • Table Product and Service Introduction of Valeant Pharmaceuticals

    • Table Company Profile and Development Status of Takeda

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda

    • Figure Sales and Growth Rate Analysis of Takeda

    • Figure Revenue and Market Share Analysis of Takeda

    • Table Product and Service Introduction of Takeda

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US